Good news, bad news on derivatives
The ever-present derivatives threat for big banks eased a bit in the first quarter.
U.S. banks’ exposure to possible derivatives losses dropped by 10% during […]
Filed under: economics by John
Comments Off
Business and Finance
The ever-present derivatives threat for big banks eased a bit in the first quarter.
U.S. banks’ exposure to possible derivatives losses dropped by 10% during […]
Filed under: economics by John
Comments Off
The window might be quickly closing on consumers’ opportunity to refinance at great rates — not their home mortgages, but their term life insurance, […]
Filed under: finance by John
Comments Off
The commercial was a LONG way from Budweiser Clydesdales and Dalmatians.
The plot: A guy stops by a convenience store to pick up a […]
Filed under: news by John
Comments Off
Sales of newly constructed homes fell unexpectedly in May and were down almost a third from last-year’s levels, a government report said Wednesday.
New home […]
Filed under: legal by John
Comments Off
A major union this week called on Morgan Stanley to reverse recent salary hikes for senior executives and other top earners, the Wall Street […]
Filed under: technology by John
Comments Off
Eleven states on Friday called for a deeper probe into the $165 million of bonuses that American International Group Inc. awarded employees in a […]
Filed under: management by John
Comments Off
Jack Welch, the former chief executive of General Electric Co, is buying a stake in an online university and will take an active role […]
Filed under: business by John
Comments Off
NYSE Euronext, the world’s top exchange operator by the size of its listings, is planning to establish a clearinghouse for fixed-income investments, the Wall […]
Filed under: money by John
Comments Off
NYSE Euronext, the world’s top exchange operator by the size of its listings, is planning to establish a clearinghouse for fixed-income investments, the Wall […]
Filed under: money by John
Comments Off
NEW YORK–Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock, getting access […]
Filed under: finance by John
Comments Off